SEC Form 13F
| Report period | 2026-06-30 |
|---|---|
| Publicly available | 2026-08-15 |
| Reported value | $398,034,838 |
| Positions | 35 |
| Issuer | Ticker | Class | Reported value | Reported amount |
|---|---|---|---|---|
| COGENT BIOSCIENCES INC | COGT | COM | $45,307,638 | 1,170,740 |
| SYNDAX PHARMACEUTICALS INC | SNDX | COM | $40,550,300 | 1,855,000 |
| CELLDEX THERAPEUTICS INC NEW | CLDX | COM NEW | $36,837,900 | 990,000 |
| RELAY THERAPEUTICS INC | RLAY | COM | $27,415,370 | 1,465,279 |
| VAXCYTE INC | PCVX | COM | $26,294,524 | 452,340 |
| VERA THERAPEUTICS INC | VERA | CL A | $18,730,987 | 436,518 |
| PHARVARIS N V | PHVS | COM | $18,180,435 | 525,750 |
| VIRIDIAN THERAPEUTICS INC | VRDN | COM | $18,093,182 | 984,931 |
| CYTOMX THERAPEUTICS INC. | CTMX | COM | $17,062,500 | 4,550,000 |
| TRAVERE THERAPEUTICS INC | TVTX | COM | $16,622,606 | 292,600 |
Public filing evidence only. NexusTrade's simulated follower strategies are hypothetical, modeled results — not live trading returns and not investment advice.